{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:50:16Z","timestamp":1791546616924,"version":"4.3.4"},"reference-count":111,"publisher":"Frontiers Media SA","funder":[{"name":"National Health and Medical Research Grant, Australia","award":["APP 1055793"],"award-info":[{"award-number":["APP 1055793"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00080","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T06:26:27Z","timestamp":1454567187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness"],"prefix":"10.3389","volume":"7","author":[{"given":"Ding Y.","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeron C.","family":"Hurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.1128\/jvi.01623-05","article-title":"Kinetics of influenza A virus infection in humans.","volume":"80","author":"Baccam","year":"2006","journal-title":"J. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.antiviral.2011.02.001","article-title":"A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A\/California\/04\/2009 (H1N1) influenza virus infection in mice.","volume":"90","author":"Bantia","year":"2011","journal-title":"Antiviral Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.1128\/jvi.01067-14","article-title":"Influenza virus infectivity and virulence following ocular-only aerosol inoculation of ferrets.","volume":"88","author":"Belser","year":"2014","journal-title":"J. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature12391","article-title":"Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice.","volume":"501","author":"Belser","year":"2013a","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2217\/fmb.13.64","article-title":"Considerations regarding appropriate sample size for conducting ferret transmission experiments.","volume":"8","author":"Belser","year":"2013b","journal-title":"Future Microbiol."},{"issue":"e0129768","key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129768","article-title":"Oseltamivir prophylaxis reduces inflammation and facilitates establishment of cross-strain protective T cell memory to influenza viruses.","volume":"10","author":"Bird","year":"2015","journal-title":"PLoS ONE"},{"key":"B7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajpath.2011.03.026","article-title":"Pathogenesis of Influenza A\/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation.","volume":"179","author":"Bodewes","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1086\/586711","article-title":"Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model.","volume":"197","author":"Boltz","year":"2008","journal-title":"J. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/v20801530","article-title":"Animal models for influenza virus pathogenesis and transmission.","volume":"2","author":"Bouvier","year":"2010","journal-title":"Viruses"},{"issue":"e07969","key":"B10","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07969","article-title":"Mapping influenza transmission in the ferret model to transmission in humans.","volume":"4","author":"Buhnerkempe","year":"2015","journal-title":"Elife"},{"key":"B11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0162-3109(99)00184-8","article-title":"Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice.","volume":"47","author":"Burger","year":"2000","journal-title":"Immunopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11308","DOI":"10.1128\/jvi.00691-08","article-title":"Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets.","volume":"82","author":"Cameron","year":"2008","journal-title":"J. Virol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jviromet.2014.04.014","article-title":"TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses.","volume":"205C","author":"Carolan","year":"2014","journal-title":"J. Virol. Methods"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02797-15","article-title":"Characterisation of the localised immune response in the respiratory tract of ferrets following infection with influenza A and B viruses.","author":"Carolan","year":"2015","journal-title":"J. Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/0091270012440280","article-title":"Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.","volume":"53","author":"Chairat","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"B16","author":"ChinaBioToday","year":"2013","journal-title":"China\u2019s SFDA Ready to Fast-Track Approvals of Peramivir, a Flu Treatment."},{"key":"B17","author":"ClinicalTrials","year":"2015","journal-title":"National Institute of Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(99)01241-6","article-title":"Influenza.","volume":"354","author":"Cox","year":"1999","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/s1473-3099(15)00068-7","article-title":"Design, recruitment, and microbiological considerations in human challenge studies.","volume":"15","author":"Darton","year":"2015","journal-title":"Lancet Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.antiviral.2015.02.011","article-title":"The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.","volume":"117","author":"Davis","year":"2015","journal-title":"Antiviral Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.virol.2015.03.017","article-title":"Ferret models of viral pathogenesis.","author":"Enkirch","year":"2015","journal-title":"Virology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1242\/dmm.014746","article-title":"Influenza A virus infection in zebrafish recapitulates mammalian infection and sensitivity to anti-influenza drug treatment.","volume":"7","author":"Gabor","year":"2014","journal-title":"Dis. Model Mech."},{"key":"B23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1529-1049(03)00064-3","article-title":"Review of rapid diagnosis tests for influenza.","volume":"4","author":"Gavin","year":"2003","journal-title":"Clin. Applied Immunol. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1128\/aac.01312-06","article-title":"Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus.","volume":"51","author":"Govorkova","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.antiviral.2011.05.008","article-title":"Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.","volume":"91","author":"Govorkova","year":"2011","journal-title":"Antiviral Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1128\/jvi.79.4.2191-2198.2005","article-title":"Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.","volume":"79","author":"Govorkova","year":"2005","journal-title":"J. Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8432","DOI":"10.1073\/pnas.1100768108","article-title":"Influenza virus aerosol exposure and analytical system for ferrets.","volume":"108","author":"Gustin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/s1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial.","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3851\/imp1794","article-title":"Reduced airborne transmission of oseltamivir-resistant pandemic A\/H1N1 virus in ferrets.","volume":"16","author":"Hamelin","year":"2011","journal-title":"Antivir. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/nejm199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections, GG167 Influenza Study Group.","volume":"337","author":"Hayden","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets.","volume":"336","author":"Herfst","year":"2012","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1086\/379049","article-title":"Assessment of development of resistance to antivirals in the ferret model of influenza virus infection.","volume":"188","author":"Herlocher","year":"2003","journal-title":"J. Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1128\/AAC.32.11.1699","article-title":"Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs.","volume":"32","author":"Hoffman","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/s0140-6736(13)61125-3","article-title":"Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.","volume":"381","author":"Hu","year":"2013","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13187","DOI":"10.1128\/jvi.01456-12","article-title":"Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection.","volume":"86","author":"Huang","year":"2012","journal-title":"J. Virol."},{"issue":"e27512","key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027512","article-title":"Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets.","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS ONE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.antiviral.2010.06.009","article-title":"Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.","volume":"87","author":"Hurt","year":"2010","journal-title":"Antiviral Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/eri.11.112","article-title":"Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.","volume":"9","author":"Ikematsu","year":"2011","journal-title":"Exp. Rev. Anti Infect Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/nature08260","article-title":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses.","volume":"460","author":"Itoh","year":"2009","journal-title":"Nature"},{"issue":"2545","key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2545","article-title":"Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.","volume":"348","author":"Jefferson","year":"2014","journal-title":"BMJ"},{"key":"B42","doi-asserted-by":"publisher","first-page":"28489","DOI":"10.1074\/jbc.M114.588541","article-title":"Glycomic characterization of respiratory tract tissues of ferrets: implications for its use in influenza virus infection studies.","volume":"289","author":"Jia","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"15940","key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/srep15940","article-title":"Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets.","volume":"5","author":"Kim","year":"2015","journal-title":"Sci. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.virol.2013.07.006","article-title":"The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus.","volume":"444","author":"Kim","year":"2013","journal-title":"Virology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.","volume":"107","author":"Kiso","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/aac.00412-11","article-title":"Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques.","volume":"55","author":"Kitano","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.antiviral.2014.06.016","article-title":"The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice.","volume":"109","author":"Kodama","year":"2014","journal-title":"Antiviral Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/00498250903447691","article-title":"Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats.","volume":"40","author":"Koyama","year":"2010","journal-title":"Xenobiotica"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1128\/aac.00731-09","article-title":"CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract.","volume":"53","author":"Koyama","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1016\/j.vaccine.2013.06.071","article-title":"Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies.","volume":"31","author":"Kreijtz","year":"2013","journal-title":"Vaccine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1128\/aac.01311-09","article-title":"Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.","volume":"54","author":"Kubo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4142\/jvs.2014.15.3.439","article-title":"Quantitative measurement of influenza virus replication using consecutive bronchoalveolar lavage in the lower respiratory tract of a ferret model.","volume":"15","author":"Lee","year":"2014","journal-title":"J. Vet. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1128\/jvi.02476-12","article-title":"Sequencing, annotation, and characterization of the influenza ferret infectome.","volume":"87","author":"Leon","year":"2013","journal-title":"J. Virol."},{"key":"B54","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.42.3.647","article-title":"Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.","volume":"42","author":"Li","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/82_2014_390","article-title":"Transmission in the guinea pig model.","volume":"385","author":"Lowen","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"9988","DOI":"10.1073\/pnas.0604157103","article-title":"The guinea pig as a transmission model for human influenza viruses.","volume":"103","author":"Lowen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B57","first-page":"41","article-title":"Development of a HEPA-filtered caging system for ferrets: thinking outside the metal box.","volume":"1","author":"Mabry","year":"2013","journal-title":"Lab. Animal Sci. Prof."},{"key":"B58","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/infdis\/jir768","article-title":"Local innate immune responses and influenza virus transmission and virulence in ferrets.","volume":"205","author":"Maines","year":"2012","journal-title":"J. Infect. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1126\/science.1177238","article-title":"Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.","volume":"325","author":"Maines","year":"2009","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/jinf.1999.0602","article-title":"Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.","volume":"40","author":"Makela","year":"2000","journal-title":"J. Infect."},{"key":"B61","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3390\/pathogens3040845","article-title":"Animal models for influenza viruses: implications for universal vaccine development.","volume":"3","author":"Margine","year":"2014","journal-title":"Pathogens"},{"key":"B62","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1128\/jvi.03513-14","article-title":"Neuraminidase mutations conferring resistance to oseltamivir in influenza A(H7N9) viruses.","volume":"89","author":"Marjuki","year":"2015","journal-title":"J. Virol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/infdis\/jiu105","article-title":"An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality.","volume":"210","author":"Marjuki","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1096\/fj.14-260687","article-title":"The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity.","volume":"29","author":"Marois","year":"2015","journal-title":"FASEB J."},{"issue":"e94090","key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094090","article-title":"Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.","volume":"9","author":"Marriott","year":"2014","journal-title":"PLoS ONE"},{"key":"B66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.vetimm.2009.05.011","article-title":"Characterization of antibodies against ferret immunoglobulins, cytokines and CD markers.","volume":"132","author":"Martel","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"149","key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422x-7-149","article-title":"Course of seasonal influenza A\/Brisbane\/59\/07 H1N1 infection in the ferret.","volume":"7","author":"McBrayer","year":"2010","journal-title":"Virol. J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3851\/imp1730","article-title":"Preventing and treating secondary bacterial infections with antiviral agents.","volume":"16","author":"McCullers","year":"2011","journal-title":"Antivir. Ther."},{"key":"B69","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/AAC.42.3.640","article-title":"Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.","volume":"42","author":"Mendel","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"13879","DOI":"10.1128\/jvi.02341-14","article-title":"Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume.","volume":"88","author":"Moore","year":"2014","journal-title":"J. Virol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.1177127","article-title":"Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.","volume":"325","author":"Munster","year":"2009","journal-title":"Science"},{"issue":"e100926","key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100926","article-title":"Influenza vaccination accelerates recovery of ferrets from lymphopenia.","volume":"9","author":"Music","year":"2014","journal-title":"PLoS ONE"},{"key":"B73","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ejps.2013.06.004","article-title":"In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.","volume":"49","author":"Nahar","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5750","key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6750","article-title":"Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors.","volume":"5","author":"Ng","year":"2014","journal-title":"Nat. Commun."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3201\/eid1912.130705","article-title":"Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011.","volume":"19","author":"Nguyen","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B76","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"issue":"e55358","key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055358","article-title":"Sample size considerations for one-to-one animal transmission studies of the influenza A viruses.","volume":"8","author":"Nishiura","year":"2013","journal-title":"PLoS ONE"},{"issue":"e0118780","key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118780","article-title":"A novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity.","volume":"10","author":"Oh","year":"2015","journal-title":"PLoS ONE"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1093\/jac\/dku146","article-title":"Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.","volume":"69","author":"Oh","year":"2014","journal-title":"J. Antimicrob Chemother."},{"key":"B80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2015.05.007","article-title":"Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection.","volume":"120","author":"Panozzo","year":"2015","journal-title":"Antiviral Res."},{"issue":"e1005173","key":"B81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005173","article-title":"Influenza transmission in the mother-infant dyad leads to severe disease, mammary gland infection, and pathogenesis by regulating host responses.","volume":"11","author":"Paquette","year":"2015","journal-title":"PLoS Pathog."},{"key":"B82","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.virol.2014.07.013","article-title":"Impaired heterologous immunity in aged ferrets during sequential influenza A H1N1 infection.","volume":"46","author":"Paquette","year":"2014","journal-title":"Virology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/nbt.3079","article-title":"The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease.","volume":"32","author":"Peng","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"e0138069","key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138069","article-title":"Oseltamivir population pharmacokinetics in the ferret: model application for pharmacokinetic\/pharmacodynamic study design.","volume":"10","author":"Reddy","year":"2015","journal-title":"PLoS ONE"},{"key":"B85","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0166-0934(89)90004-9","article-title":"Assessment of signs of influenza illness in the ferret model.","volume":"24","author":"Reuman","year":"1989","journal-title":"J. Virol. Methods"},{"key":"B86","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature12476","article-title":"Limited airborne transmission of H7N9 influenza A virus between ferrets.","volume":"501","author":"Richard","year":"2013","journal-title":"Nature"},{"issue":"e43303","key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043303","article-title":"Transmission of a 2009 H1N1 pandemic influenza virus occurs before fever is detected, in the ferret model.","volume":"7","author":"Roberts","year":"2012","journal-title":"PLoS ONE"},{"key":"B88","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent.","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.virol.2010.02.020","article-title":"Modeling host responses in ferrets during A\/California\/07\/2009 influenza infection.","volume":"401","author":"Rowe","year":"2010","journal-title":"Virology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jim.2008.04.003","article-title":"Screening monoclonal antibodies for cross-reactivity in the ferret model of influenza infection.","volume":"336","author":"Rutigliano","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1128\/AAC.38.10.2270","article-title":"Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase).","volume":"38","author":"Ryan","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"B92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.antiviral.2012.07.002","article-title":"Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.","volume":"96","author":"Smee","year":"2012a","journal-title":"Antiviral Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1128\/aac.01664-12","article-title":"Exacerbation of influenza virus infections in mice by intranasal treatments and implications for evaluation of antiviral drugs.","volume":"56","author":"Smee","year":"2012b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B94","doi-asserted-by":"publisher","first-page":"7572","DOI":"10.1128\/jvi.00512-11","article-title":"Comparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts.","volume":"85","author":"Smith","year":"2011","journal-title":"J. Virol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0140-6736(00)78541-2","article-title":"A virus obtained from influenza patients.","volume":"222","author":"Smith","year":"1933","journal-title":"Lancet"},{"issue":"e58337","key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058337","article-title":"Clinical profiles associated with influenza disease in the ferret model.","volume":"8","author":"Stark","year":"2013","journal-title":"PLoS ONE"},{"key":"B97","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.","volume":"117","author":"Takashita","year":"2015","journal-title":"Antiviral Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jim.2014.03.023","article-title":"Animal models for influenza virus pathogenesis, transmission, and immunology.","volume":"410","author":"Thangavel","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(98)10190-3","article-title":"Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.","volume":"352","author":"The MIST","year":"1998","journal-title":"Lancet"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"issue":"e7788","key":"B101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007788","article-title":"Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS ONE"},{"key":"B102","first-page":"600","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider.","volume":"50","author":"Turner","year":"2011","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"B103","first-page":"33","article-title":"A short introduction to pharmacokinetics.","volume":"6","author":"Urso","year":"2002","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"e1003343","key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003343","article-title":"Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.","volume":"9","author":"van der Vries","year":"2013","journal-title":"PLoS Pathog."},{"issue":"e1002276","key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002276","article-title":"Multidrug resistant 2009 A\/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets.","volume":"7","author":"van der Vries","year":"2011","journal-title":"PLoS Pathog."},{"issue":"85","key":"B106","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-014-0085-8","article-title":"Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung.","volume":"45","author":"Vidana","year":"2014","journal-title":"Vet. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1750-2659.2011.00235.x","article-title":"Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung.","volume":"5","author":"Wong","year":"2011","journal-title":"Influenza Other Respir. Viruses"},{"key":"B108","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1128\/jvi.00170-07","article-title":"Inefficient transmission of H5N1 influenza viruses in a ferret contact model.","volume":"81","author":"Yen","year":"2007","journal-title":"J. Virol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.virol.2007.12.029","article-title":"Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A\/Vietnam\/1203\/04 (H5N1).","volume":"374","author":"Yun","year":"2008","journal-title":"Virology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.lfs.2011.12.014","article-title":"Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A\/California\/04\/2009 (H1N1).","volume":"90","author":"Zarogiannis","year":"2012","journal-title":"Life Sci."},{"key":"B111","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1126\/science.1240532","article-title":"H7N9 influenza viruses are transmissible in ferrets by respiratory droplet.","volume":"341","author":"Zhang","year":"2013","journal-title":"Science"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T07:52:22Z","timestamp":1567583542000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00080\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,4]]},"references-count":111,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00080","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,4]]}}}